Indication
Acute myocardial infarction
Acute myocardial infarction is a life-threatening cardiovascular emergency characterized by acute myocardial cell necrosis resulting from prolonged myocardial ischemia. Read more about Acute myocardial infarction
210 drugs 130 manufacturers
Drugs that treat it
Common Acute myocardial infarction therapies.
LISINOPRIL
METOPROLOL TARTRATE
METOPROLOL TARTRATE
LISINOPRIL
METOPROLOL TARTRATE
LISINOPRIL
METOPROLOL TARTRATE
ATENOLOL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAcute myocardial infarction is a life-threatening cardiovascular emergency characterized by acute myocardial cell necrosis resulting from prolonged myocardial ischemia.
It most commonly develops when an unstable atherosclerotic plaque ruptures or erodes within a coronary artery, provoking platelet aggregation and acute thrombus formation that severely impedes or entirely halts downstream blood flow.
Patients typically present with ischemic symptoms, such as acute retrosternal chest pain, dyspnea, and diaphoresis.
Clinically, it is classified within the acute coronary syndromes as either ST-segment elevation myocardial infarction or non–ST-segment elevation myocardial infarction, confirmed by a dynamic rise and fall of cardiac biomarkers, primarily cardiac troponin, alongside electrocardiographic or imaging evidence of acute regional ischemia.
- nih.gov
Acute myocardial infarction is a life-threatening cardiovascular emergency characterized by acute myocardial cell necrosis resulting from prolonged myocardial ischemia It most commonly develops when an unstable atherosclerotic plaque ruptures or erodes within a coronary artery, provoking platelet aggregation and acute thrombus formation that severely impedes or entirely halts downstream blood flow
- merckmanuals.com
Acute myocardial infarction is a life-threatening cardiovascular emergency characterized by acute myocardial cell necrosis resulting from prolonged myocardial ischemia It most commonly develops when an unstable atherosclerotic plaque ruptures or erodes within a coronary artery, provoking platelet aggregation and acute thrombus formation that severely impedes or entirely halts downstream blood flow Patients typically present with ischemic symptoms, such as acute retrosternal chest pain, dyspnea, ...
- nih.gov
It most commonly develops when an unstable atherosclerotic plaque ruptures or erodes within a coronary artery, provoking platelet aggregation and acute thrombus formation that severely impedes or entirely halts downstream blood flow
- nih.gov
Patients typically present with ischemic symptoms, such as acute retrosternal chest pain, dyspnea, and diaphoresis Clinically, it is classified within the acute coronary syndromes as either ST-segment elevation myocardial infarction or non–ST-segment elevation myocardial infarction, confirmed by a dynamic rise and fall of cardiac biomarkers, primarily cardiac troponin, alongside electrocardiographic or imaging evidence of acute regional ischemia
- nih.gov
Clinically, it is classified within the acute coronary syndromes as either ST-segment elevation myocardial infarction or non–ST-segment elevation myocardial infarction, confirmed by a dynamic rise and fall of cardiac biomarkers, primarily cardiac troponin, alongside electrocardiographic or imaging evidence of acute regional ischemia
Personalize your experience
Follow Acute myocardial infarction and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.